Skip to main content
SpringerLink
Log in

Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs

Relation to diarrheagenic activity, leukocyte infiltration, and mucosal leukotrienes

  • Esophageal, Gastric, and Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

To determine the mode of protective effects of misoprostol against the chronic gastrointestinal ulceration from the NSAID, diclofenac, studies were undertaken in domestic pigs, a model of human gastrointestinal ulceration, to determine (1) the effects of repeated daily dosing for 10 days of diclofenac 5 mg/kg/day twice a day (as Voltaren tablets) on the gastrointestinal morphology,59Fe-red blood loss, mucosal myeloperoxidase (MPO) activity (as an indicator of leukocyte infiltration), and mucosal leukotrienes (LTs); and (2) the mucosal protective effects of 10–40 μg/kg/day misoprostol twice a day (as Cytotec tablets) given with diclofenac 5 mg/kg/day twice a day compared with diclofenac 5 mg/kg/day alone and aspirin 150 mg/kg/twice a day (USP tablets) as a standard. These effects were compared with the dose range for potential diarrheagenic effects of misoprostol (determined by fecal analysis of Na+, K+, Cl−, Ca2+, H2O, and phenol red transit) given alone or with diclofenac to determine if this could be discriminated from antiulcer effects of misoprostol. Plasma and gastric mucosal concentrations of the drugs were determined to establish if misoprostol affects diclofenac absorption/elimination, andvice versa. The results showed that: (1) diclofenac produced gastric mucosal damage without any prior or concurrent bleeding from the gastrointestinal tract, although aspirin significantly increased blood loss; (2) misoprostol produced a dose-related reduction in diclofenac-induced mucosal damage of the upper gastrointestinal tract; (3) no significant increase in mucosal MPO occurred with diclofenac despite mucosal damage being evident, (4) mucosal LTs were unaffected by the drug treatments; (5) plasma, gastric and intestinal concentrations of diclofenac were not affected by misoprostol, while conversely plasma misoprostol concentrations were not influenced by the diclofenac treatment; (6) no significant effects on fecal water, electrolyte, or phenol red transit times were observed with any of the drug-treatments; and (7) mild diarrhea observed as “loose bowel motions” was only observed in most pigs receiving the misoprostol treatments during fasting on days 9–10. Thus, misoprostol protects against chronic lesions/ulcers in the upper gastrointestinal tract from diclofenac without: (1) signs of diarrhea becoming evident (the latter occurring when there is reduced food intake), (2) generalized leukocyte infiltration or effects on mucosal LTs, or (3) any reduction in bioavailability of diclofenac.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Prostaglandins in the Upper Gastrointestinal Tract. Focus on Misoprostol. Proceedings of the second international symposium. New York City, May 9–10, 1985. Dig Dis Sci 31(suppl.):1S–145S, 1986

  2. Dajani EZ, Agrawal NM: Protective effects of prostaglandins against non-steroidal anti-inflammatory drug-induced gastro-intestinal mucosal injury. Int J Clin Pharmacol Res 9:359–369, 1989

    Google Scholar 

  3. Hopkinson N, Doherty M: NSAID-associated gastropathy—a role for misoprostol? Br J Rheumatol 29:133–136, 1990

    Google Scholar 

  4. Miller TA: Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms. Am J Physiol 245:G601-G623, 1983

    Google Scholar 

  5. Dajani EZ, Callison DA, Bertrmann RE: Effects of E-prostaglandins on canine gastric potential difference. Am J Dig Dis 23:436–442, 1978

    Google Scholar 

  6. Colton DG, Callison DA, Dajani EZ: Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther 210:283–288, 1979

    Google Scholar 

  7. Gullikson GW, Anglin CP, Kessler LK, Smeach S, Bauer RF, Dajani EZ: Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa. Clin Invest Med 10:145–151, 1987

    Google Scholar 

  8. Graham DY: Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 96:675–681, 1989

    Google Scholar 

  9. Agrawal NM, Dajani EZ: Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. J Rheumatol 17(suppl 20):7–11, 1990

    Google Scholar 

  10. Rainsford KD: Mechanisms of gastrointestinal ulceration from nonsteroidal antiinflammatory drugs: A basis for use and development of therapeutic agents.In Side Effects of Anti-inflammatory Drugs—3. KD Rainsford, GP Velo (eds). Lancaster, Kluwer, 1992, pp 97–114

    Google Scholar 

  11. Bach G: Arthrotec, product symposium. Abstracts of the XIth European Congress of Rheumatology, June 30–July 6, 1991, Budapest, Hungary. Hungarian Rheumatology Abstr., 249(suppl):SP5–24, 1991

    Google Scholar 

  12. Rainsford KD: Gastric mucosal ulceration induced by tablets but not suspensions or solutions of aspirin in pigs. J Pharm Pharmacol 30:129–131, 1978

    Google Scholar 

  13. Rainsford KD, Willis C: Relationship of gastric mucosal damage induced in pigs by anti-inflammatory drugs to their effects on prostaglandin production. Dig Dis Sci 27:624–635, 1982

    Google Scholar 

  14. Rachmilewitz D: Prostaglandins and diarrhea. Dig Dis Sci 25:897–899, 1980

    Google Scholar 

  15. Donowitz M, Wicks J, Cusolito S, Sharp GWG: Pharmacotherapy of diarrhoeal diseases: An approach based on physiologic principles. PROC Found Ser 17:329–359, 1984

    Google Scholar 

  16. Riviere PJM, Farmer SC, Burks TF, Poreca F: Prostaglandin E2-induced diarrhea in mice: importance of colonic secretion. J Pharmacol Exp Ther 256:547–552, 1991

    Google Scholar 

  17. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344–1350, 1984

    Google Scholar 

  18. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157–167, 1985

    Google Scholar 

  19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275, 1951

    Google Scholar 

  20. Schoenhard G, Oppermann J, Kohn FE: Metabolism and pharmacokinetic studies of misoprostol. Dig Dis Sci 30:126S-128S, 1985

    Google Scholar 

  21. Rainsford KD, Fox SA, Osborne DJ: Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake. Scand J Gastroenterol 19(suppl 101):55–68, 1984

    Google Scholar 

  22. Powell WS: Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol 86:467–477, 1982

    Google Scholar 

  23. Powell WS: Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclo-oxygenases and lipoxygenases. Anal Biochem 148:56–69, 1985

    Google Scholar 

  24. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS: Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain in varying origin. Drugs 20:24–48, 1980

    Google Scholar 

  25. Catalano MA: Worldwide Safety experience with diclofenac. Am J Med 80(suppl 4B):81–87, 1986

    Google Scholar 

  26. Clarke RJ, Mayo G, Price P, Fitzgerald GA: Suppression of thromboxane but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 325:1137–1141, 1991

    Google Scholar 

  27. Hawkey CJ: The ulcerogenic and anti-haemostatic effects of NSAIDs in the gut.In Side Effects of Anti-inflammatory Drugs—3. KD Rainsford, GP Velo (eds). Lancaster, Kluwer, 1992, pp 54–58

    Google Scholar 

  28. Soffer EE, Launspach J: Effect of misoprostol on postprandial intestinal motility and oro-cecal transit time in humans. Dig Dis Sci 38:851–855, 1993

    Google Scholar 

  29. Liauw L, Moscaritola JD, Burcher J: Diclofenac.In: Nonsteroidal Anti-Inflammatory Drugs. Mechanisms and Clinical Use. AJ Lewis, DE Furst (eds). New York, Marcel Dekker, 1987, pp 329–347

    Google Scholar 

  30. Leese PT, Karim A, Rozek L: Technical and pharmacological considerations in evaluating misoprostol pharmacokinetic data. Dig Dis Sci 31:147S, 1986

    Google Scholar 

  31. Wallace JL, Keenan CM, Granger DN: Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 259:G462-G467, 1990

    Google Scholar 

  32. Trevethick MA, Bahl AK, Clayton NM, Strong P, Sanjar S, Harman IW: Neutrophil infiltration does not contribute to the ulcerogenic effects of indomethacin in the rat gastric antrum. Agents Actions 43:39–43, 1994

    Google Scholar 

  33. Rainsford KD: Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage. Agents Actions 39:C24-C26, 1993

    Google Scholar 

  34. Rainsford KD: The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by non-steroidal anti-inflammatory drugs in mice. Agents Actions 21:316–319, 1987

    Google Scholar 

  35. Vaananen PM, Keenan CM, Grisham MB, Wallace JL: Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy. Inflammation 16:227–240, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Biomedical Sciences and Pathology, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

    K. D. Rainsford FRCPath, PhD, W. E. Perkins PhD & P. I. Stetsko BSc

  2. Division of Biomedical Sciences & Health Research Institute, Sheffield Hallam University, Pond Street, S1 1WB, Sheffield, England, UK

    K. D. Rainsford FRCPath, PhD, W. E. Perkins PhD & P. I. Stetsko BSc

Authors
  1. K. D. Rainsford FRCPath, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. E. Perkins PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. I. Stetsko BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rainsford, K.D., Perkins, W.E. & Stetsko, P.I. Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Digest Dis Sci 40, 1435–1444 (1995). https://doi.org/10.1007/BF02285189

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02285189

Key Words

Search

Navigation